Baseline characteristics for patients with hyperactive, hypoactive, mixed and no-subtype delirium
| Hyperactive (n=15) | Hypoactive (n=20) | Mixed (n=17) | No-subtype (n=8) | P value* | |
| Mean (SD) | |||||
| Age (years) | 86.3 (6.3) | 85.5 (4.4) | 88.7 (4.7) | 86.1 (5.8) | 0.28 |
| p-ADL Function Barthel Index score (0–20) | 16.3 (3.3) | 14.2 (4.6) | 15.8 (2.8) | 16.5 (4.1) | 0.29 |
| Cognitive Function GDS score (1-7) | 4.5 (1.5) | 4.1 (1.1) | 4.0 (1.4) | 3.8 (1.0) | 0.58 |
| Physical Function SPPB score (0–12) | 4.2 (3.8) | 1.2 (1.5) | 2.1 (2.9) | 5.1 (3.0) | 0.003 |
| Drugs on admittance (no) | 6.1 (4.0) | 6.8 (2.8) | 6.9 (3.5) | 5.5 (2.3) | 0.73 |
| Acute Illness APACHE II score (0–71) | 8.5 (1.9) | 10.0 (3.6) | 9.5 (2.5) | 9.6 (2.4) | 0.49 |
| Comorbidity CIRS score (0–56) | 14.6 (4.6) | 16.0 (4.5) | 14.9 (4.5) | 14.8 (4.6) | 0.81 |
| Body mass index (kg/m²) | 24.8 (2.3) | 23.6 (3.8) | 23.3 (3.9) | 21.6 (4.5) | 0.28 |
| No (%) | |||||
| Female (%) | 8 (53) | 8 (40) | 10 (59) | 5 (63) | 0.61 |
| Living at home (%) | 12 (80) | 18 (90) | 17 (100) | 8 (100) | 0.17 |
| Dementia† (%) | 10 (67) | 15 (75) | 13 (77) | 5 (63) | 0.86 |
*P values are calculated using one-way analysis of variance for continuous variables and Pearson’s χ2 test for categorical variables.
†Global Deterioration Scale ≥4.
CIRS, Cumulative Illness Rating Scale; GDS, Global Deterioration Scale; p-ADL, personal activities of daily living; SPPB, Short Physical Performance Battery; APACHE II, Acute Physiology and Chronic Health Evaluation II.